The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
Open accessAbstract
SUMMARY Chronically activated leukocytes recruited to premalignant tissues functionally contribute to cancer development; however, mechanisms underlying pro- versus anti-tumor programming of neoplastic tissues by immune cells remain obscure. Using the K14-HPV16 mouse model of squamous carcinogenesis, we report that B cells and humoral immunity foster cancer development by activating Fcγ receptors (FcγRs) on resident and recruited myeloid cells. Stromal accumulation of autoantibodies in premalignant skin, through their interaction with activating FcγRs, regulate recruitment, composition, and bioeffector functions of leukocytes in neoplastic tissue, which in turn promote neoplastic progression and subsequent carcinoma development. These findings support a model in which B cells, humoral immunity, and activating FcγRs are required for establishing chronic inflammatory programs that promote de novo carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947 · cited 8×
“Four classes of IgG receptor FcγRs have been identified, FcγRI/CD64, FcγRII/CD32, FcγRIII/CD16, and FcγRIV, differing by their distinct affinity for IgG isotypes, cellular distributions, and effector functions (Nimmerjahn and Ravetch, 2008).”
InfluentialParadoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Self-citationStatistical analysis of real-time PCR data
Yuan, J. S., Reed, A., Chen, F., & Stewart, C. N. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-85 · Cited by 2,195
DeNardo, D. G., Barreto, J. B., Andreu, P., Vasquez, L., Tawfik, D., Kolhatkar, N., & Coussens, L. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.018 · Cited by 1,353
Self-citationMMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Self-citationFcR γ chain deletion results in pleiotrophic effector cell defects
Takai, T., Li, M., Sylvestre, D., Clynes, R., & Ravetch, J. V. (1994) · Cell · doi:10.1016/0092-8674(94)90115-5 · Cited by 951
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946 · cited 7×
“FcγRIII+ mast cells regulate tissue remodeling, angiogenesis, and keratinocyte hyperproliferation in HPV16 mice (Coussens et al., 1999; Coussens et al., 2000), thus we evaluated whether FcRγ-dependent activation of mast cells was in part necessary for neoplastic progression.”
InfluentialSelf-citation“Re-educating” tumor-associated macrophages by targeting NF-κB
Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080108 · Cited by 792 · cited 2×
“In contrast, in ovarian cancer, macrophage phenotype is regulated by IL-1R and MyD88, which together maintain a macrophage immunosuppressive M2 phenotype (Hagemann et al., 2008).”
Modulation of the antitumor immune response by complement
Markiewski, M. M., DeAngelis, R. A., Benencia, F., Ricklin-Lichtsteiner, S. K., Koutoulaki, A., Gerard, C., Coukos, G., & Lambris, J. D. (2008) · Nature Immunology · doi:10.1038/ni.1655 · Cited by 778
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
de Visser, K. E., Korets, L. V., & Coussens, L. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.014 · Cited by 715
Self-citationGiraudo, E., Inoue, M., & Hanahan, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422087 · Cited by 700
Soucek, L., Lawlor, E. R., Soto, D., Shchors, K., Swigart, L. B., & Evan, G. I. (2007) · Nature Medicine · doi:10.1038/nm1649 · Cited by 507
Immune surveillance: a balance between protumor and antitumor immunity
Ostrand-Rosenberg, S. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.007 · Cited by 480
Macrophages define the invasive microenvironment in breast cancer
Pollard, J. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107762 · Cited by 417
Humoral immunity, inflammation and cancer
Tan, T.-T., & Coussens, L. M. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.01.001 · Cited by 417
Self-citationChen, J., Trounstine, M., Alt, F. W., Young, F., Kurahara, C., Loring, J. F., & Huszar, D. (1993) · International Immunology · doi:10.1093/intimm/5.6.647 · Cited by 393
Mast cells: the JEKYLL and HYDE of tumor growth
Theoharides, T. C., & Conti, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.02.013 · Cited by 351
Pucci, F., Venneri, M. A., Biziato, D., Nonis, A., Moi, D., Sica, A., Di Serio, C., Naldini, L., & De Palma, M. (2009) · Blood · doi:10.1182/blood-2009-01-200931 · Cited by 328
Self-citationA review of the current use of rituximab in autoimmune diseases
Gürcan, H. M., Keskin, D. B., Stern, J. N. H., Nitzberg, M. A., Shekhani, H., & Ahmed, A. R. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2008.10.004 · Cited by 314
Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice
Arbeit, J. M., Münger, K., Howley, P. M., & Hanahan, D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4358-4368.1994 · Cited by 305
De Palma, M., Mazzieri, R., Politi, L. S., Pucci, F., Zonari, E., Sitia, G., Mazzoleni, S., Moi, D., Venneri, M. A., Indraccolo, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.09.004 · Cited by 301
Self-citationFc Receptors and Their Role in Immune Regulation and Autoimmunity
Takai, T. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-0353-8 · Cited by 231
Shah, S., Divekar, A. A., Hilchey, S. P., Cho, H.-M., Newman, C. L., Shin, S.-U., Nechustan, H., Challita-Eid, P. M., Segal, B. M., Yi, K. H., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21177 · Cited by 227
Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice.
Coussens, L. M., Hanahan, D., & Arbeit, J. M. (1996) · Europe PMC (PubMed Central) · Cited by 206
Self-citationChronic immune activation and inflammation in the pathogenesis of aids and cancer
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84008-8 · Cited by 166
The B-Cell System in Inflammatory Bowel Disease
Brandtzæg, P., Carlsen, H. S., & Halstensen, T. S. (2006) · Advances in experimental medicine and biology · doi:10.1007/0-387-33778-4_10 · Cited by 165
Mast cell–derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors
Nakayama, T., Yao, L., & Tosato, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22089 · Cited by 151
Barberá‐Guillem, E., Nelson, M. B., Barr, B. L., Nyhus, J. K., May, K. F., Feng, L., & Sampsel, J. W. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/pl00006672 · Cited by 138
FcR-Bearing Myeloid Cells Are Responsible for Triggering Murine Lupus Nephritis
Bergtold, A., Gavhane, A., D’Agati, V. D., Madaio, M. P., & Clynes, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7287 · Cited by 122
A new allele sash (Wsh) at theW-locus and a spontaneous recessive lethal in mice
Lyon, M. F., & Glenister, P. H. (1982) · Genetics Research · doi:10.1017/s001667230002098x · Cited by 96
Baumann, U., Chouchakova, N., Gewecke, B., Köhl, J., Carroll, M. C., Schmidt, R. E., & Gessner, J. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.1022 · Cited by 87
CD4+ T Cell-Mediated Antigen-Specific Immunotherapy in a Mouse Model of Cervical Cancer
Daniel, D., Chiu, C. W., Giraudo, E., Inoue, M., Mizzen, L., Chu, N., & Hanahan, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3444 · Cited by 82
Arbeit, J. M., Olson, D., & Hanahan, D. (1996) · PubMed · Cited by 76
Barberá‐Guillem, E., May, K. F., Nyhus, J. K., & Nelson, M. B. (1999) · Neoplasia · doi:10.1038/sj.neo.7900054 · Cited by 73
Siegel, C., Schreiber, K., Meredith, S. C., Beck‐Engeser, G., Lancki, D. W., Lazarski, C. A., Fu, Y., Rowley, D. A., & Schreiber, H. W. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1945 · Cited by 58
Early Neoplastic Progression Is Complement Independent
de Visser, K. E., Korets, L. V., & Coussens, L. M. (2004) · Neoplasia · doi:10.1593/neo.04250 · Cited by 50
Self-citationZapata, J. M., Llobet‐Navàs, D., Krajewska, M., Lefebvre, S., Kress, C. L., & Reed, J. C. (2008) · Blood · doi:10.1182/blood-2008-07-165456 · Cited by 49
Analysis of Immune Cell Infiltrates during Squamous Carcinoma Development
Junankar, S. R., Eichten, A., Kramer, A., de Visser, K. E., & Coussens, L. M. (2006) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsymp.5650024 · Cited by 27
Self-citation
Cited by
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Metadata
- Authors
- Andreu, P., Johansson, M., Affara, N. I., Pucci, F., Tan, T., Junankar, S., Korets, L., Lam, J., Tawfik, D., DeNardo, D. G., Naldini, L., de Visser, K. E., De Palma, M., & Coussens, L. M.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 17
- Issue
- 2
- Pages
- 121-134
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2130085747
- Cited by
- 590
- References
- 39
- FWCI
- 20.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.